Innovotech, Inc. (IOT) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Innovotech, Inc. has changed its score on 25 Nov 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared positive results in Sep'2024 after 4 consecutive negative quarters

PRE-TAX PROFIT(Q) At CAD 0.06 MM has Grown at 511.5%
NET PROFIT(Q) At CAD 0.06 MM has Grown at 405.42%
OPERATING CASH FLOW(Y) Highest at CAD 0.08 MM

With ROE of -0.43%, it has a very expensive valuation with a 4.12 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 12 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.20

Return on Equity

-0.43%

Price to Book

5.16

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Jun 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-2.38%

6 Months

-25.45%

1 Year

17.14%

2 Years

127.78%

3 Years

36.67%

4 Years

10.81%

5 Years

7.89%

Innovotech, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Innovotech Reports Significant Profit Growth Amid Positive Valuation Shift

Innovotech, Inc. has recently seen a positive adjustment in its evaluation, reflecting a notable improvement in its financial performance. The company reported significant growth in quarterly profits and operating cash flow, while its stock has outperformed the S&P/TSX 60 index over the past year.

Innovotech Experiences Mixed Technical Signals Amid Valuation Adjustment in Biotechnology Sector

Innovotech, Inc. has undergone a recent evaluation adjustment, reflecting changes in its technical and valuation metrics. The company's technical indicators show mixed signals, while its valuation remains attractive despite a non-applicable P/E ratio due to losses. Key metrics include a Price to Book Value of 4.43 and an EV to Sales ratio of 2.81.

Innovotech, Inc. Adjusts Valuation Amid Mixed Technical Indicators and Market Dynamics

Innovotech, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its evaluation metrics, indicating a shift in its valuation. The company's financial landscape remains complex, with mixed technical indicators suggesting a nuanced market position amid ongoing adjustments.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

29.77%

EBIT Growth (5y)

0.79%

EBIT to Interest (avg)

-0.04

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

1.19

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.64%

ROE (avg)

10.24%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.12

EV to EBIT

-9.45

EV to EBITDA

9.45

EV to Capital Employed

4.93

EV to Sales

2.61

PEG Ratio

Dividend Yield

ROCE (Latest)

-2.09%

ROE (Latest)

-0.43%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -16.67% vs 20.00% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -300.00% vs -80.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.00",
          "val2": "1.20",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "0.10",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "0.10",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-214.30%",
          "val2": "79.10%",
          "chgp": "-29.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 83.33% vs 9.09% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 200.00% vs -100.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.20",
          "val2": "1.20",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.30",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.20",
          "val2": "-0.20",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-80.00%",
          "val2": "-356.10%",
          "chgp": "27.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

1.00

1.20

-16.67%

Operating Profit (PBDIT) excl Other Income

-0.20

0.10

-300.00%

Interest

0.00

Exceptional Items

0.10

0.00

Consolidate Net Profit

-0.20

0.10

-300.00%

Operating Profit Margin (Excl OI)

-214.30%

79.10%

-29.34%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -16.67% vs 20.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -300.00% vs -80.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2.20

1.20

83.33%

Operating Profit (PBDIT) excl Other Income

-0.10

-0.30

66.67%

Interest

0.00

Exceptional Items

0.20

Consolidate Net Profit

0.20

-0.20

200.00%

Operating Profit Margin (Excl OI)

-80.00%

-356.10%

27.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 83.33% vs 9.09% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 200.00% vs -100.00% in Dec 2023

All Annual Results

Company CV

About Innovotech, Inc.

Innovotech, Inc.

Pharmaceuticals & Biotechnology

Innovotech Inc is a Canada-based company, which operates in the field of biofilm product development, practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company's current products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbal biofilms for research purposes. The Company's products are effective against such diseases as Powdery Mildew on lettuce, White Mould on beans, Bacterial Spot on tomatoes and Fire Blight on apples. The Company's products include InnovoSIL, MBEC Assay Agress and AgreGuard.

Company Coordinates

Company Details

2011 94 St NW Suite 101 , EDMONTON AB : T6N 1H1

Tel: 1 780 4480585

http://www.innovotech.ca/

Registrar Details

Innovotech, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

The company has declared positive results in Sep'2024 after 4 consecutive negative quarters

With ROE of -0.43%, it has a very expensive valuation with a 4.12 Price to Book Value

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Innovotech Reports Significant Profit Growth Amid Positive Valuation Shift

Innovotech Experiences Mixed Technical Signals Amid Valuation Adjustment in Biotechnology Sector

Innovotech, Inc. Adjusts Valuation Amid Mixed Technical Indicators and Market Dynamics

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Innovotech, Inc.

Company Coordinates